UAB researchers find a chemical pathway — a glutamate transporter — that may be causing seizures and shorten survival rates for patients with brain tumors.
UAB is one of five centers named to host the first class of fellows in the Edmond J. Safra Fellowship in Movement Disorders.
UAB has established the third multidisciplinary comprehensive clinic in the world for transverse myelitis, a rare spinal cord disease.
UAB has received prestigious designation as a Comprehensive Stroke Center from the Joint Commission and American Heart Association.
Research to identify a new approach to treat Alzheimer’s disease gets new funding after a pilot grant from the Alabama Drug Discovery Alliance.
Robin Lorenz, M.D., Ph.D. and Anthony Nicholas, M.D., Ph.D., were honored with the UAB President’s Award for Excellence in Teaching.
The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid.
A new study says that the cost of a medication may play a very important role in a patient’s perception of whether it works.
UAB has launched one of the first clinics in the nation designed to provide healthy adults with an assessment of their risk for Alzheimer’s disease.
A ramped-up immune response may play a major role in autism disorders, according to a new study from UAB and Johns Hopkins.